Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04188041 · ClinicalTrials.gov registry record · NA

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care

A NA study, sponsored by Kent Hospital, Rhode Island.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT04188041 is a NA study that has completed, run by Kent Hospital, Rhode Island. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04188041, a NA study, has completed, sponsored by Kent Hospital, Rhode Island.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

This study explores primary care team members' knowledge, attitudinal, and skill gaps related to latent tuberculosis infection (LTBI) testing and treatment. The gaps identified will inform the design of a survey and telementoring educational program (tuberculosis (TB) infection ECHO course). The EMR data query will further explore the reach of the expansion for community healthcare outcomes (ECHO) model. The hypothesis for this study is that the TB infection ECHO course will be feasible, will have a significant impact on primary care provider participants' learning and performance related to LTBI testing and treatment in their primary care practices, and will increase the number of LTBI tests and treatment prescribed in primary care.

Interventions

  • OTHER TB Infection ECHO

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2019-10-02
Est. Completion 2022-07-31
Phase NA

Sponsor

Kent Hospital, Rhode Island

2 total trials

What the Registry Record Tells You About NCT04188041

The ClinicalTrials.gov registry entry for NCT04188041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kent Hospital, Rhode Island, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which TB Infection ECHO is the first listed.

NCT04188041 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04188041 about?

NCT04188041 is a clinical study titled "Improving Rhode Island's Tuberculosis Preventive Services in Primary Care". This study explores primary care team members' knowledge, attitudinal, and skill gaps related to latent tuberculosis infection (LTBI) testing and treatment. The gaps identified will inform the design of a survey and telementoring educational program (tuberculosis (TB) infection ECHO course). The EMR...

What is the current status of trial NCT04188041?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-10-02. Estimated completion is 2022-07-31.

What interventions are being tested in trial NCT04188041?

The interventions under investigation include: TB Infection ECHO (OTHER).

Who is sponsoring clinical trial NCT04188041?

This trial is sponsored by Kent Hospital, Rhode Island, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.